These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain. Koga H, Araki N, Takeshima H, Nishi T, Hirota T, Kimura Y, Nakao M, Saya H. Oncogene; 1998 Aug 20; 17(7):801-10. PubMed ID: 9779996 [Abstract] [Full Text] [Related]
27. A 163-bp deletion in the neurofibromatosis 2 (NF2) gene associated with variant phenotypes [corrected]. Kluwe L, Pulst SM, Köppen J, Mautner VF. Hum Genet; 1995 Apr 20; 95(4):443-6. PubMed ID: 7705843 [Abstract] [Full Text] [Related]
28. Double somatic SMARCB1 and NF2 mutations in sporadic spinal schwannoma. Paganini I, Capone GL, Vitte J, Sestini R, Putignano AL, Giovannini M, Papi L. J Neurooncol; 2018 Mar 20; 137(1):33-38. PubMed ID: 29230670 [Abstract] [Full Text] [Related]
29. Segmental neurofibromatosis type 2: discriminating two hit from four hit in a patient presenting multiple schwannomas confined to one limb. Castellanos E, Bielsa I, Carrato C, Rosas I, Solanes A, Hostalot C, Amilibia E, Prades J, Roca-Ribas F, Lázaro C, Blanco I, Serra E, NF2 Multidisciplinary Clinics HUGTiP-ICO-IMPPC. BMC Med Genomics; 2015 Jan 24; 8():2. PubMed ID: 25739810 [Abstract] [Full Text] [Related]
30. NF2 tumor suppressor gene: a comprehensive and efficient detection of somatic mutations by denaturing HPLC and microarray-CGH. Szijan I, Rochefort D, Bruder C, Surace E, Machiavelli G, Dalamon V, Cotignola J, Ferreiro V, Campero A, Basso A, Dumanski JP, Rouleau GA. Neuromolecular Med; 2003 Jan 24; 3(1):41-52. PubMed ID: 12665675 [Abstract] [Full Text] [Related]
31. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Papi L, De Vitis LR, Vitelli F, Ammannati F, Mennonna P, Montali E, Bigozzi U. Hum Genet; 1995 Mar 24; 95(3):347-51. PubMed ID: 7868131 [Abstract] [Full Text] [Related]
35. Screening for large mutations of the NF2 gene. Kluwe L, Nygren AO, Errami A, Heinrich B, Matthies C, Tatagiba M, Mautner V. Genes Chromosomes Cancer; 2005 Apr 24; 42(4):384-91. PubMed ID: 15645494 [Abstract] [Full Text] [Related]
36. PTEN is not altered in sporadic vestibular schwannomas. Mawrin C, Kirches E, Boltze C, Dietzmann K. Histopathology; 2002 Jun 24; 40(6):526-30. PubMed ID: 12047763 [Abstract] [Full Text] [Related]
37. Genetics of familial and non-familial skull base tumours. Irving RM, Moffat DA, Maher ER. Clin Otolaryngol Allied Sci; 1995 Feb 24; 20(1):5-11. PubMed ID: 7788935 [Abstract] [Full Text] [Related]
38. Molecular characterization of chromosome 22 deletions in schwannomas. Bijlsma EK, Brouwer-Mladin R, Bosch DA, Westerveld A, Hulsebos TJ. Genes Chromosomes Cancer; 1992 Oct 24; 5(3):201-5. PubMed ID: 1384671 [Abstract] [Full Text] [Related]
39. Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes. Kluwe L, Bayer S, Baser ME, Hazim W, Haase W, Fünsterer C, Mautner VF. Hum Genet; 1996 Nov 24; 98(5):534-8. PubMed ID: 8882871 [Abstract] [Full Text] [Related]
40. Analysis of the neurofibromatosis type 2 gene in different human tumors of neuroectodermal origin. De Vitis LR, Tedde A, Vitelli F, Ammannati F, Mennonna P, Bono P, Grammatico B, Grammatico P, Radice P, Bigozzi U, Montali E, Papi L. Hum Genet; 1996 May 24; 97(5):638-41. PubMed ID: 8655145 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]